Former Novo Nordisk employee plans to revolutionize market for insulin pens

Ole Kjerkegaard Nielsen has devoted most of his life to CSR and now he and collaborative partner Michael Ejstrup Hansen are ready to send new insulin pen on the market.
Photo: Mik Eskestad/ERH
Photo: Mik Eskestad/ERH
BY BENJAMIN WERNER CHRISTENSEN, FINANS, TRANSLATED BY NIELSINE NIELSEN

The world' poorest diabetes patients have billions to save and better every-day lives ahead of them, if the ambitions and dreams of the former Novo Nordisk Project Director Ole Kjerkegaard Nielsen and his partner Michael Ejstrup Hansen come to fruition.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading